This trial is testing the effectiveness of a new type of radiation therapy called TrueBeam in treating prostate cancer. The hope is that this new therapy will be more effective in treating the tumor while minimizing injury to nearby healthy tissue.
- Prostate Cancer
1 Primary · 0 Secondary · Reporting Duration: 5 years
Awards & Highlights
0 Treatment Group
167 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age Any Age · Male Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any available vacancies for this research endeavor?
"Data accessible on clinicaltrials.gov reports that this trial is in its recruitment stage, with the first post being made on June 5th 2018 and the last update taking place November 3rd 2022." - Anonymous Online Contributor
What is the current cohort size of this research study?
"Affirmative. Clinicaltrials.gov's data suggests that this research endeavor, which was initially posted on June 5th 2018, is currently soliciting participants. Approximately 167 individuals must be recruited from a single center." - Anonymous Online Contributor